Cardioprotective Effects of Red Ginger Extracted Using Natural Deep Eutectic Solvent on Lipid Profile in Atherosclerotic Rats
Article Sidebar
-
Atherosclerosis, Dyslipidemia, Lipid profile, Natural Deep Eutectic Solvent, Red ginger
Abstract
Atherosclerosis, a leading cause of cardiovascular disease, is closely related to dyslipidemia. This study evaluated the cardioprotective effects of red ginger (Zingiber officinale var. rubrum) extracted using a Natural Deep Eutectic Solvent (NADES) on lipid profiles and the risk of atherosclerosis in rats induced with an atherogenic diet and lipopolysaccharide (LPS). Thirty male Sprague-Dawley rats were divided into five groups: normal control, negative control, positive control (Simvastatin), and two treatment groups receiving red ginger extract at 25 mg/kg and 50 mg/kg body weight (BW). After 24 days of treatment, the 25 mg/kg BW dose significantly reduced total and LDL cholesterol while increasing HDL levels compared with the negative control (p < 0.05), showing comparable effects to Simvastatin. The 50 mg/kg BW dose did not significantly reduce total and LDL cholesterol but produced the highest HDL level. All treatment groups showed a significantly lower Atherogenic Index of Plasma (AIP) than the negative control, with the lowest AIP in the 50 mg/kg BW group. These findings demonstrate the cardioprotective potential of red ginger extracted with NADES as a natural, environmentally friendly approach to preventing dyslipidemia and atherosclerosis.
Full text article
References
Boroujeni, H. R., Gharipour, M., & Samani, M. A. (2016). The protective effects of ginger on the development of coronary atherosclerosis: An experimental animal study. Der Pharmacia Lettre, 8(3), 105–109. https://www.researchgate.net/publication/301632214
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6), 7204–7218. https://doi.org/10.18632/oncotarget.23208
Craveiro, R., Aroso, I., Flammia, V., Carvalho, T., Viciosa, M. T., Dionísio, M., Barreiros, S., Reis, R. L., Duarte, A. R. C., & Paiva, A. (2016). Properties and thermal behavior of natural deep eutectic solvents. Journal of Molecular Liquids, 215, 534–540. https://doi.org/10.1016/j.molliq.2016.01.038
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18(6), 499–502. https://doi.org/10.1093/clinchem/18.6.499
Gorabi, A. M., Kiaie, N., Khosrojerdi, A., Jamialahmadi, T., Al-Rasadi, K., Johnston, T. P., & Sahebkar, A. (2022). Implications for the role of lipopolysaccharide in the development of atherosclerosis. Trends in Cardiovascular Medicine, 32(8), 525–533. https://doi.org/10.1016/j.tcm.2021.08.015
Harborne, J. B. (2015). Phytochemical methods: A guide to modern techniques of plant analysis. Springer.
Hsieh, Y.-H., Li, Y., Pan, Z., Chen, Z., Lu, J., Yuan, J., Zhu, Z., & Zhang, J. (2020). Ultrasonication-assisted synthesis of alcohol-based deep eutectic solvents for extraction of active compounds from ginger. Ultrasonics Sonochemistry, 63, 104915. https://doi.org/10.1016/j.ultsonch.2019.104915
Jasaputra, D. K., Christiandy, A., & Sanjaya, A. (2025). The exploration of 6-gingerol and 6-shogaol using network pharmacology and molecular docking as potential inhibitors of atherogenesis. Tropical Journal of Natural Product Research, 9(3). https://doi.org/10.26538/tjnpr/v9i3.22
Jodynis-Liebert, J., & Kujawska, M. (2020). Biphasic dose-response induced by phytochemicals: Experimental evidence. Journal of Clinical Medicine, 9(3), 718. https://doi.org/10.3390/jcm9030718
Kemenkes. (2016). Profil kesehatan Indonesia 2016. Kementerian Kesehatan Republik Indonesia. https://pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Profil-Kesehatan-Indonesia-2016.pdf
Mahmudati, N. (2016). Seduhan jahe menurunkan ekspresi TNF-α pada tikus putih yang diberi diet tinggi lemak (HFD). Proceeding Biology Education Conference, 13(1), 653–655.
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019). Targeting early atherosclerosis: A focus on oxidative stress and inflammation. Oxidative Medicine and Cellular Longevity, 2019, 1–32. https://doi.org/10.1155/2019/8563845
McCann, M. R., & Ratneswaran, A. (2019). The role of PPARγ in childhood obesity-induced fractures. Genes & Nutrition, 14, 31. https://doi.org/10.1186/s12263-019-0653-7
Niroumand, S., Khajedaluee, M., Khadem-Rezaiyan, M., Abrishami, M., Juya, M., Khodaee, G., & Dadgarmoghaddam, M. (2015). Atherogenic index of plasma (AIP): A marker of cardiovascular disease. Medical Journal of the Islamic Republic of Iran, 29, 240.
Nirvana, R., Dewi, P., & Supriyadi, D. (2020). The effect of red ginger extract on lipid profile in hyperlipidemic rats. Journal of Traditional Medicine Research, 5(2), 45–52.
PERKI. (2022). Panduan prevalensi penyakit kardiovaskular aterosklerosis (2nd ed., I. A. Arso, Ed.). Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. https://www.inaheart.org/storage/guideline/d14e4316bb1608b200e47523f364f6b1.pdf
Samota, M. K., Rawat, M., Kaur, M., & Garg, D. (2024). Gingerol: Extraction methods, health implications, bioavailability and signaling pathways. Sustainable Food Technology, 2(6), 1652–1669. https://doi.org/10.1039/D4FB00135D
Shahjehan, R. D., Sharma, S., & Bhutta, B. S. (2024). Coronary artery disease. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK564304/
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020). Herbal medicine for cardiovascular diseases: Efficacy, mechanisms, and safety. Frontiers in Pharmacology, 11, 422. https://doi.org/10.3389/fphar.2020.00422
Wakhidatun, S. S., Sukrasno, Fisheri Kurniati, N., & Adnyana, I. K. (2024). Bioactive substances from red ginger rhizome (Zingiber officinale Roscoe var. sunti Val) as an anti-atherosclerotic agent: Inhibition of lipoxygenase in arachidonic acid metabolism. Research Journal of Pharmacy and Technology, 17(10), 4901–4906. https://doi.org/10.52711/0974-360X.2024.00754
Wang, Y., Hong, Y., Yao, Y., Huang, X., Liu, X., Zhang, C., Zhang, L., & Xu, X. (2013). 6-Shogaol protects against oxidized LDL-induced endothelial injuries by inhibiting oxidized LDL-evoked LOX-1 signaling. Evidence-Based Complementary and Alternative Medicine, 2013, 503521. https://doi.org/10.1155/2013/503521
WHO. (2021). Cardiovascular diseases (CVDs) – Fact sheet. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Yulianita, Y., Mun’im, A., Yanuar, A., & Saputri, F. C. (2024). Analysis of gingerol and shogaol compounds from red ginger (Zingiber officinale var. rubrum) extract using several combinations of natural deep eutectic solvent. International Journal of Applied Pharmaceutics, 16(s3), 51–55. https://doi.org/10.22159/ijap.2024.v16s3.09
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Copyright @2017. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted non-commercial used, distribution and reproduction in any medium